<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Attana AB - videor</title>
    <link>http://www.mynewsdesk.com/se/pressroom/attana-ab/video/list</link>
    <description>Mynewsdesk nyhetsfeed direkt fr&#229;n k&#228;llan</description>
    <image>
      <title>Attana AB - videor</title>
      <link>http://www.mynewsdesk.com/se/pressroom/attana-ab/video/list</link>
      <url>http://www.mynewsdesk.com/images/redesign/graphics/logos/logo-small.png</url>
      <width>126</width>
      <height>22</height>
    </image>
    <language>sv</language>
    <ttl>15</ttl>
    <item>
      <title>Attana on Today in America</title>
      <pubDate>Wed, 02 Mar 2011 09:00:00 +0100</pubDate>
      <description>
          &lt;a href="/se/pressroom/attana-ab/video/view/attana-on-today-in-america-2125" title="Attana on Today in America"&gt;&lt;img alt="Thumb_r-mdg4l6gw_h6gg53eegqq" src="http://csp.picsearch.com/img/R/-/m/D/thumb_R-mDG4l6gW_H6GG53EegqQ.jpg" /&gt;&lt;/a&gt;
          &lt;p&gt;Attana is featured in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to &#8220;Improving Diagnostic Outcomes through Biosensor Technology&#8221; as part of the show&#8217;s &#8220;Medical Minutes&#8221; series. In the clip we find out why biological relevance is important and how it is possible to shorten the time between research initiation and new drug on the market.&lt;/p&gt;
        </description>
      <guid>http://www.mynewsdesk.com/se/pressroom/attana-ab/video/view/attana-on-today-in-america-2125</guid>
      <link>http://www.mynewsdesk.com/se/pressroom/attana-ab/video/view/attana-on-today-in-america-2125</link>
      <dc:creator>Attana AB</dc:creator>
      <media:content url="http://csp.picsearch.com/players/rutile.swf?config=http%3A//csp.picsearch.com/playlist%3Fauth%3DHczGCzo493D1pOhZbmMA04A_gsjS9G2HPijwZDEYSTwznQ4o4U0VUZ0YhbnvrSAJhJliMu41oek8z-nkn8jUmLr4RVCgrpjM" type="application/x-shockwave-flash" medium="video" expression="full" duration="300"/>
      <media:thumbnail url="http://csp.picsearch.com/img/R/-/m/D/thumb_R-mDG4l6gW_H6GG53EegqQ.jpg"/>
      <media:player url="http://www.mynewsdesk.com/se/pressroom/attana-ab/video/view/attana-on-today-in-america-2125"/>
      <media:title type="plain">Attana on Today in America</media:title>
      <media:description type="plain">Attana is featured in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to &#8220;Improving Diagnostic Outcomes through Biosensor Technology&#8221; as part of the show&#8217;s &#8220;Medical Minutes&#8221; series. In the clip we find out why biological relevance is important and how it is possible to shorten the time between research initiation and new drug on the market.</media:description>
    </item>
    <item>
      <title>Attana Cell Biosensor</title>
      <pubDate>Fri, 14 Jan 2011 09:00:00 +0100</pubDate>
      <description>
          &lt;a href="/se/pressroom/attana-ab/video/view/attana-cell-200-bionsensor-4535" title="Attana Cell Biosensor"&gt;&lt;img alt="Thumb_kmh6myudvi96_ukkygiyhq" src="http://csp.picsearch.com/img/K/m/h/6/thumb_Kmh6mYuDVi96_uKkygIYHQ.jpg" /&gt;&lt;/a&gt;
          &lt;p&gt;The Attana Cell 200 biosensor has the unique ability to determine label-free kinetics directly on the cell surface, therefore disclosing the full complexity of the interaction at a very early stage. By delivering biologically relevant information this early in the research process, The Attana Cell 200 minimizes costs and increases success during clinical trials.(produced by TTV AB)&lt;/p&gt;
        </description>
      <guid>http://www.mynewsdesk.com/se/pressroom/attana-ab/video/view/attana-cell-200-bionsensor-4535</guid>
      <link>http://www.mynewsdesk.com/se/pressroom/attana-ab/video/view/attana-cell-200-bionsensor-4535</link>
      <dc:creator>Attana AB</dc:creator>
      <media:content url="http://csp.picsearch.com/players/rutile.swf?config=http%3A//csp.picsearch.com/playlist%3Fauth%3D3rFzYWNgsSk3EhZQdS3sivSTVq_CXDgb_7VEN50V9yp7R3UzPGJrzwFRd-SrWqMRZhY4_ReIdcT724775-8Ll6qiM5p_U29d" type="application/x-shockwave-flash" medium="video" expression="full" duration="84"/>
      <media:thumbnail url="http://csp.picsearch.com/img/K/m/h/6/thumb_Kmh6mYuDVi96_uKkygIYHQ.jpg"/>
      <media:player url="http://www.mynewsdesk.com/se/pressroom/attana-ab/video/view/attana-cell-200-bionsensor-4535"/>
      <media:title type="plain">Attana Cell Biosensor</media:title>
      <media:description type="plain">The Attana Cell 200 biosensor has the unique ability to determine label-free kinetics directly on the cell surface, therefore disclosing the full complexity of the interaction at a very early stage. By delivering biologically relevant information this early in the research process, The Attana Cell 200 minimizes costs and increases success during clinical trials.(produced by TTV AB)</media:description>
    </item>
    <item>
      <title>Antibody - Antigen characterization using the Attana Label Free Sensor Technology</title>
      <pubDate>Fri, 02 Oct 2009 12:53:46 +0200</pubDate>
      <description>
          &lt;a href="/se/pressroom/attana-ab/video/view/antibody-antigen-characterization-using-the-attana-label-free-sensor-technology-2108" title="Antibody - Antigen characterization using the Attana Label Free Sensor Technology"&gt;&lt;img alt="Thumb_iqeaautasqussjvx5e9svq" src="http://csp.picsearch.com/img/i/Q/e/A/thumb_iQeAAUtAsquSsjvX5E9sVQ.jpg" /&gt;&lt;/a&gt;
          &lt;p&gt;This movie shows Monoclonal Antibody - Antigen Characterization and provides information on Kinetics &amp; Affinity, Selection, Specificity and Concentration using the Attana Quartz Crystal Microbalance systems. 
www. attana.com&lt;/p&gt;
        </description>
      <guid>http://www.mynewsdesk.com/se/pressroom/attana-ab/video/view/antibody-antigen-characterization-using-the-attana-label-free-sensor-technology-2108</guid>
      <link>http://www.mynewsdesk.com/se/pressroom/attana-ab/video/view/antibody-antigen-characterization-using-the-attana-label-free-sensor-technology-2108</link>
      <dc:creator>Attana AB</dc:creator>
      <media:content url="http://csp.picsearch.com/players/rutile.swf?config=http%3A//csp.picsearch.com/playlist%3Fauth%3DvGmGRkLkfAt2DK5qNuTmqwMjZd8F85kZu_MVnkUH8ZwCKrxRJPKGB5UVvpWbR0oUxvFuJbeslbw7KxCLIf7C-UZc4dNLZTeR" type="application/x-shockwave-flash" medium="video" expression="full" duration="183"/>
      <media:thumbnail url="http://csp.picsearch.com/img/i/Q/e/A/thumb_iQeAAUtAsquSsjvX5E9sVQ.jpg"/>
      <media:player url="http://www.mynewsdesk.com/se/pressroom/attana-ab/video/view/antibody-antigen-characterization-using-the-attana-label-free-sensor-technology-2108"/>
      <media:title type="plain">Antibody - Antigen characterization using the Attana Label Free Sensor Technology</media:title>
      <media:description type="plain">This movie shows Monoclonal Antibody - Antigen Characterization and provides information on Kinetics &amp; Affinity, Selection, Specificity and Concentration using the Attana Quartz Crystal Microbalance systems. 
www. attana.com</media:description>
    </item>
  </channel>
</rss>

